Special Issue "The Past, Present, and Future of mRNA Vaccines"
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Cellular/Molecular Immunology".
Deadline for manuscript submissions: closed (1 January 2021) | Viewed by 243071
Special Issue Editor
Interests: mRNA vaccines targeting infectious diseases and cancer, therapy with mRNA-encoded monoclonal antibodies, gene therapy with mRNA
Special Issue Information
Dear Colleagues,
Vaccines represent one of the most successful interventions of modern medicine. Currently used vaccine types have many shortfalls, and, thus, the development of next-generation vaccines that are safe, easy-to-produce, and offer broad and durable protection against a wide range of pathogens and have the ability to eliminate various types of cancer is urgently needed. mRNA vaccines have the potential to meet these criteria and, thus, represent one of the most promising new generation vaccine modalities.
This Special Issue of Vaccines will provide a series of peer-reviewed perspective and review articles that discuss the current standing and speculate on the future of the field of mRNA vaccines. This Special Issue will discuss a broad range of topics including recent developments in various types of infectious disease and cancer mRNA vaccines, passive immunization with mRNA, delivery materials, and production of mRNA vaccines, among other topics.
Keywords
- mRNA vaccines
- nucleoside modification
- Flaviviruses
- Cancer
- HIV-1
- SARS-CoV-2